SG2000
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SG2000, covering 2015-11-23 to 2015-11-23. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability Study of SG2000 in the Treatment of Advanced Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia [Phase 1, Phase 2]